ADN 0.00% 0.7¢ andromeda metals limited

General comments/chat, page-26775

  1. 2,537 Posts.
    lightbulb Created with Sketch. 2084
    This is the kind of calibre of board members that would do wonders for us. Example here is from a pharma stock some of us are in.
    https://au.wallmine.com/asx/rac/officer/1895232/john-cullity
    I like the fact that he has huge subject matter expertise (pharma, for us this would be geo) coupled with an
    impressive background in investment banking.
    Plus, he has done a number of really big commercail deals:
    He has been involved in over 100 licensing and M&A transactions in the life sciences arena, with a combined value in excess of US$10 billion, including the licensing of Antisoma’s oral oncology drug fludarabine by Sanofi, and Kineta’s oncology RIG-I inhibitor by Pfizer.
    If we wonna go big, we gotta think big and get s.b. like that. Imagine where we'd go with a person (equivalent to our industry) on the Board! Who knows one?
 
watchlist Created with Sketch. Add ADN (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $24.00M
Open High Low Value Volume
0.7¢ 0.7¢ 0.6¢ $205.4K 33.70M

Buyers (Bids)

No. Vol. Price($)
26 15764082 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 9234658 18
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
ADN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.